Risk prediction of four of more metastastatic axillary lymph nodes after macrometastatic sentinel node biopsy Risk prediction of having four or more metastatic axillary lymph nodes (pN2-disease) after macrometastatic sentinel node finding Prevalence of pN2-disease in Series Insert here the percentual prevalence of pN2-disease in the given institution. The reference prevalence in our manuscript is 19.1%. Prevalence of pN2-disease in Series % Histological Size of the Primary Tumor Insert here the largest histological size of the primary invasive breast cancer in millimeters. Histological Size of the Primary Tumor mm Number of Tumor-Negative Sentinel Nodes Insert here the number of tumor-negative sentinel nodes harvested in the sentinel node biopsy procedure. Number of Tumor-Negative Sentinel Nodes Number of Tumor-Positive Sentinel Nodes Insert here the number of tumor-positive sentinel nodes harvested in the sentinel node biopsy procedure. Number of Tumor-Positive Sentinel Nodes 1 2 3 Extra-Capsular Extension of the Sentinel Node Metastasis Choose between "yes" or "no" to indicate whether there is an extra-capsular extension of the tumor growth in any of the tumor-positive sentinel nodes. Extra-Capsular Extension of the Sentinel Node Metastasis No Yes Probability of pN2-disease The result indicates the risk prediction of having four or more tumor-positive axillary lymph nodes after macrometastatic sentinel node finding. Probability of pN2-disease Excel-based nomogram Excel-based nomogram(xls 33.5 KB) (Avautuu uuteen ikkunaan. Linkki vie toiselle verkkosivulle.) Original article (Avautuu uuteen ikkunaan. Linkki vie toiselle verkkosivulle.) Tulosta tämä sivu